Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

RF, Spaide; K, Laud; HF, Fine; JM Jr, Klancnik; CB, Meyerle; LA, Yannuzzi; J, Sorenson; J, Slakter; YL, Fisher; MJ, Cooney

doi:10.1097/01.iae.0000238561.99283.0e

Public

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

Shared by NobleBlocks on Apr 1, 2006 • 12:00 AM UTC

Authors:

Spaide RF

Laud K

Fine HF

Abstract

Purpose To describe the short-term anatomical and visual acuity responses after intravitreal injection of bevacizumab (Avastin, Genentech) in patients with choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD).Methods We conducted a retrospective study of patients wi...

Discussions